The Pharmacy and Medicines Regulatory Authority (PMRA) and the National AIDS Commission (NAC) are pleased to announce the registration of Lenacapavir, an innovative, long-acting medicine that is used for the prevention of HIV-1 infection.

Read full statement in the link below: